GPNMB and Parkinson disease: Our GPNMB MR finding was consistent with a transcriptome-wide association study (TWAS) conducted by Li et al [36] on the Nalls et al [37] Parkinson’s disease GWAS, who also found that increased GPNMB expression in dorsolateral prefrontal cortex and peripheral monocytes was associated with increased disease risk.